Myocardial Infarction: Current Status and Future Challenges

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 22 August 2024 | Viewed by 98

Special Issue Editors


E-Mail Website
Guest Editor
1. Heart Area, Hospital Universitario Central Asturias (HUCA), 33011 Oviedo, Spain
2. Department of Medicine, University of Oviedo, 33003 Oviedo, Spain
3. Health Research Institute of Asturias (ISPA), 33011 Oviedo, Spain
Interests: inherited cardiomyopathies; sudden cardiac death; coronary artery disease (CAD); cardiovascular risk factors, pharmacological therapy, acute coronary syndrome (ACS); ischemic heart disease; percutaneous coronary intervention; transcatheter valvular devices

E-Mail Website
Co-Guest Editor
1. National Reference Unit of Inherited Cardiomyopathies, Hospital Universitario Central Asturias (HUCA), 33011 Oviedo, Spain
2. Department of Medicine, University of Oviedo, 33003 Oviedo, Spain
3. Health Research Institute of Asturias (ISPA), 33011 Oviedo, Spain
Interests: inherited cardiomyopathies; genetics; arrhythmias; heart failure; sudden cardiac death; coronary artery disease; cardiovascular risk factors; pharmacological therapy

Special Issue Information

Dear Colleagues,

Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, with coronary artery disease (CAD) being a major concern. In this regard, acute coronary syndrome (ACS), especially with myocardial infarction (MI), can be one of the most life-threating manifestations of CAD. It is crucial to identify and manage risk factors to prevent the development of premature CAD and its associated complications. CAD is a complex disease with multiple risk factors, including genetics, lifestyle, and environmental factors. Myocardial infarction is a significant health concern that requires early diagnosis, effective management, and ongoing prevention.

This Special Issue, entitled “Myocardial Infarction: Current Status and Future Challenges”, aims to provide a comprehensive platform to bring together contributions from international researchers in the area of myocardial infarction. As a result, we invite all researchers to submit their studies.

Dr. Isaac Pascual
Dr. Rebeca Lorca
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • myocardial infarction
  • acute coronary syndrome (ACS)
  • ischemic heart disease
  • coronary artery disease (CAD)
  • percutaneous coronary intervention
  • pharmacological therapy
  • cardiovascular risk factors

Published Papers

This special issue is now open for submission.
Back to TopTop